A comparative randomized field trial on intramammary and intramuscular dry cow antibiotic treatment of subclinical Staphylococcus aureus mastitis in dairy cows

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 53, Issue 8, 2006, Pages 418-422

  Shpigel, N Y ^a   Kass, P H ^a,b   Saran, A ^a,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KIMRON VETERINARY INSTITUTE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CELL COUNT; COMPARATIVE STUDY; CYTOLOGY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MICROBIOLOGY; MILK; RANDOMIZATION; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CELL COUNT; FEMALE; INJECTIONS, INTRAMUSCULAR; MASTITIS, BOVINE; MILK; RANDOM ALLOCATION; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

BOS TAURUS; STAPHYLOCOCCUS AUREUS;

EID: 33748690751     PISSN: 0931184X     EISSN: 14390442     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2006.00848.x     Document Type: Article

References (19)

1. Apilab Plus, 1990: Bacterial identification software. BioMerieux SA, Marcy- 1'Etoile, France.
2. Barnes-pallesen, F. D., P. Blackmer, A. Britten, R. B. Bushnell, D. M. van Damme, and F. Welcome, 1987: Laboratory and Field Handbook on Bovine Mastitis. National Mastitis Council Inc., Washington, DC.
3. Brown, R. W., D. A. Barnum, D. E. Jasper, J. S. Mcdonald, and W. D. Schnitze, 1982: Microbiological Procedures for Use in the Diagnosis of Bovine Mastitis, 2nd edn. National Mastitis Council, Inc., Washington, DC.
4. Browning, J. W., G. A. Mein, M. Barton, T. J. Nicholls, and P. Brightling, 1990: Effects of antibiotic therapy at drying off on mastitis in the dry period and early lactation, Aust. Vet, J. 67, 440-442.
5. Dingwell, R. T., K. E. Leslie, T. F. Duffield, Y. H. Schukken, L. DesCoteaux, G. P. Keefe, D. F. Kelton, K. D. Lissemore, W. Shewfelt, P. Dick, and R. Bagg, 2003: Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period, J. Dairy Sci. 86, 159-168.
6. Erskine, R. J., P. C. Bartlett, P. C. Crawshaw, and D. M. Gombas, 1994: Efficacy of intramuscular oxytetracycline as a dry cow treatment for Staphylococcus aureus mastitis, J. Dairy Sci. 77, 3347-3353.
7. Guerin-Faublee, V., G. Carret, and P. Houffschmitt, 2003: In vitro activity of 10 antimicrobial agents against bacteria isolated from cows with clinical mastitis. Vet. Rec. 152, 466-471.
8. Hensen, S. M., M. J. Pavicic, J. A. Lohuis, and B. Poutrel, 2000: Use of bovine primary mammary epithelial cells for the comparison of adherence and invasion ability of Staphylococcus aureus strains. J. Dairy Sci. 83, 418-429.
9. Manila, T., S. Saari, H. Vartiala, and M. Sandholm, 1985: Milk antitrypsin as a marker of bovine mastitis correlation with bacteriology. J. Dairy Sci. 68, 114-122.
10. Murdoch, M. B., and L. R. Peterson, 1991: Antimicrobial penetration into polymorphonuclear leukocytes and alveolar macrophages. Semin. Respir. Infect. 6, 112-121,
11. Nickerson, S. C., W. E. Owens, L. K. Fox, C. C. Scheifinger, T. R. Shryock, and T. E. Spike, 1999: Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off. J. Dairy Sci. 82, 696-703.
12. Osteras, O., and L. Sandvik, 1996: Effects of selective dry-cow therapy on culling rate, clinical mastitis, milk yield and cow somatic cell count. A randomized clinical field study in cows. Zentralbl Veterinarmed B 43, 555-575.
13. Osteras, O., V. L. Edge, and S. W. Martin, 1999: Determinants of success or failure in the elimination of major mastitis pathogens in selective dry cow therapy. J. Dairy Sci. 82, 1221-1231.
14. Osteras, O., L. Sandvik, J. Aursjo, G. G. Ojul, and A. Jorstad, 1991: Assessment of strategy in selective dry cow therapy for mastitis control. Zentralbl Veterinarmed B. 38, 513-522.
15. Sader, H. S., and R. N. Jones, 1993: The fourth-generation cephalosporins: antimicrobial activity and spectrum definitions using cefpirome as an example. The Antimicrobic Newsletter 9, 9-16.
16. Schmid, P., A. Bottner, and R. Humke, 1994: In vitro testing of bacterial field strains from bovine origin for sensitivity to cefquinome. Proceedings of the 18th World Buiatric Congress Bologna, Italy, August 29-Sept 2, 1994. 539-542.
17. Shpigel, N. Y., D. Levin, M. Winkler, A. Saran, G. Ziv, and A. Bottner, 1996: Efficacy of the fourth generation cephalosporin cefquinome for the treatment of experimentally induced Escherichia coli mastitis in cows. Dairy Sci. 80, 318-323.
18. Soback, S., G. Ziv, M. Winkler, and A. Saran, 1990: Systemic dry cow therapy- a preliminary report. J. Dairy Sci. 73, 661-666.
19. Sol, J., O. C. Sampimon, J. J. Snoep, and Y. H. Schukken, 1994: Factors associated with bacteriological cure after dry cow treatment of subclinical staphylococcal mastitis with antibiotics. J. Dairy Sci. 77, 75-79.